Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Christine D Berg"'
Autor:
Claire S Zhu, Paul F Pinsky, James E Moler, Andrew Kukwa, Jerome Mabie, Joshua M Rathmell, Tom Riley, Philip C Prorok, Christine D Berg
Publikováno v:
PLoS Medicine, Vol 14, Iss 5, p e1002304 (2017)
Paul Pinsky of the US National Cancer Institute and colleagues describe the implementation and outcomes of web-based data sharing from the PLCO and NLST cancer screening trials.
Externí odkaz:
https://doaj.org/article/10fe45ff8b114fe1963939140825b313
Autor:
Martin C Tammemägi, Timothy R Church, William G Hocking, Gerard A Silvestri, Paul A Kvale, Thomas L Riley, John Commins, Christine D Berg
Publikováno v:
PLoS Medicine, Vol 11, Iss 12, p e1001764 (2014)
BACKGROUND: Lung cancer risks at which individuals should be screened with computed tomography (CT) for lung cancer are undecided. This study's objectives are to identify a risk threshold for selecting individuals for screening, to compare its effici
Externí odkaz:
https://doaj.org/article/82c8b6b19b8c419f9fc01f9a8f08b7ee
Autor:
Daniele Campa, Myrto Barrdahl, Konstantinos K Tsilidis, Gianluca Severi, W Ryan Diver, Afshan Siddiq, Stephen Chanock, Robert N Hoover, Regina G Ziegler, Christine D Berg, Saundra S Buys, Christopher A Haiman, Brian E Henderson, Fredrick R Schumacher, Loïc Le Marchand, Dieter Flesch-Janys, Sara Lindström, David J Hunter, Susan E Hankinson, Walter C Willett, Peter Kraft, David G Cox, Kay-Tee Khaw, Anne Tjønneland, Laure Dossus, Dimitrios Trichopoulos, Salvatore Panico, Carla H van Gils, Elisabete Weiderpass, Aurelio Barricarte, Malin Sund, Mia M Gaudet, Graham Giles, Melissa Southey, Laura Baglietto, Jenny Chang-Claude, Rudolf Kaaks, Federico Canzian
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e85955 (2014)
Approximately 15-30% of all breast cancer tumors are estrogen receptor negative (ER-). Compared with ER-positive (ER+) disease they have an earlier age at onset and worse prognosis. Despite the vast number of risk variants identified for numerous can
Externí odkaz:
https://doaj.org/article/778d297c569547c1b30533a543c545f5
Autor:
Nicolas Wentzensen, Amanda Black, Kevin Jacobs, Hannah P Yang, Christine D Berg, Neil Caporaso, Ulrike Peters, Lawrence Ragard, Saundra S Buys, Stephen Chanock, Patricia Hartge
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21731 (2011)
A recent ovarian cancer genome-wide association study (GWAS) identified a locus on 9p22 associated with reduced ovarian cancer risk. The single nucleotide polymorphism (SNP) markers localize to the BNC2 gene, which has been associated with ovarian de
Externí odkaz:
https://doaj.org/article/3047cc10296d46859a661109d98c0492
Autor:
Alpa V Patel, Iona Cheng, Federico Canzian, Loïc Le Marchand, Michael J Thun, Christine D Berg, Julie Buring, Eugenia E Calle, Stephen Chanock, Francoise Clavel-Chapelon, David G Cox, Miren Dorronsoro, Laure Dossus, Christopher A Haiman, Susan E Hankinson, Brian E Henderson, Robert Hoover, David J Hunter, Rudolf Kaaks, Laurence N Kolonel, Peter Kraft, Jakob Linseisen, Eiliv Lund, Jonas Manjer, Catherine McCarty, Petra H M Peeters, Malcolm C Pike, Michael Pollak, Elio Riboli, Daniel O Stram, Anne Tjonneland, Ruth C Travis, Dimitrios Trichopoulos, Rosario Tumino, Meredith Yeager, Regina G Ziegler, Heather Spencer Feigelson, Breast and Prostate Cancer Cohort Consortium
Publikováno v:
PLoS ONE, Vol 3, Iss 7, p e2578 (2008)
IGF-1 has been shown to promote proliferation of normal epithelial breast cells, and the IGF pathway has also been linked to mammary carcinogenesis in animal models. We comprehensively examined the association between common genetic variation in the
Externí odkaz:
https://doaj.org/article/013951d6fc58498c82f70fd04ae1f26d
Autor:
Katie E. Lichter, Justin Anderson, Austin J. Sim, Claire C. Baniel, Cassandra L. Thiel, Robert Chuter, Amy Collins, Erin Carollo, Christine D Berg, C. Norman Coleman, May Abdel-Wahab, Surbhi Grover, Lisa Singer, Osama Mohamad
Publikováno v:
Int J Radiat Oncol Biol Phys
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Establishing a cancer screening biomarker's intended performance requires “phase III” specimens obtained in asymptomatic individuals before clinical diagnosis rather than “phase II” specimens obtained from symptomatic individuals at diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf1e70b162e8cd9fbba21a5004249ba5
https://doi.org/10.1158/1940-6207.c.6544857
https://doi.org/10.1158/1940-6207.c.6544857
Autor:
Nicole Urban, Claire S. Zhu, Zhen Zhang, David C. Ward, Sudhir Srivastava, Patrick M. Sluss, Steven J. Skates, Nathalie Scholler, Mark D. Thornquist, Paul F. Pinsky, Christos Patriotis, Gil Mor, Martin W. McIntosh, Karen H. Lu, Anna E. Lokshin, Patricia Hartge, Andrew K. Godwin, Eleftherios P. Diamandis, Christine D. Berg, Robert C. Bast, Daniel W. Cramer
Perspectives on This Article from Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0327c80f36bfd0572b80a18ce723774d
https://doi.org/10.1158/1940-6207.22525686.v1
https://doi.org/10.1158/1940-6207.22525686.v1
Autor:
Amanda Black, Hormuzd A. Katki, Robert L. Grubb, Christine D. Berg, Lauren C. Houghton, Rebecca Landy
Longer-than-annual screening intervals have been suggested to improve the balance of benefits and harms in prostate cancer screening. Many researchers, societies, and guideline committees have suggested that screening intervals could depend on the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6234bc48fbba50b1d6d31ec7b16b0fc
https://doi.org/10.1158/1940-6207.c.6547666.v1
https://doi.org/10.1158/1940-6207.c.6547666.v1
Autor:
Christine D. Berg, Saundra S. Buys, Sudhir Srivastava, Christos Patriotis, Adele M. Marrangoni, Karen H. Lu, Nathalie Scholler, Patrick M. Sluss, Eric T. Fung, Aleksey Lomakin, James T. Symanowski, David C. Ward, Zhen Zhang, Allison Vitonis, Steven J. Skates, Martin W. McIntosh, Anna E. Lokshin, Lee E. Moore, Robert C. Bast, Gil Mor, Nicole Urban, Ruth M. Pfeiffer, Patricia Hartge, David F. Ransohoff, Daniel W. Cramer, Paul F. Pinsky, Claire S. Zhu
A panel of biomarkers may improve predictive performance over individual markers. Although many biomarker panels have been described for ovarian cancer, few studies used prediagnostic samples to assess the potential of the panels for early detection.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5efdfd15abacb677fe17610c36b679fb
https://doi.org/10.1158/1940-6207.c.6544599
https://doi.org/10.1158/1940-6207.c.6544599